"i don't like the way agen is doing business,"
What is it you don't like about the business they're doing?
Well yes, that is part of 'working capital and general corporate puposes;' requirements.
You don't expect a sharp mgt team like Amarin's to work for less than the best remuneration do you?
For a fee of $4M they get $27.5M to 2032, convertible to common at $2.60 with an interest rate of 3.5%.
Expensive money but that's the position they're in. I don't know if I'd want to be holding that note even at the price Amarin is paying.
Either the SEC starts to figure out what's happening and fixes the problems or these markets cannot last.
The market in small caps is more like a free-for-all casino than the orderly market it's supposed to be.
The problem was the invasive procedure needed to deliver the drug. Docs were afraid they'd do more damage than good. The inhalation method eliminates that issue but now we need to establish efficacy. Will the mist deliver enough drug to do the job. The trial results suggest that that might be the case but is not conclusive and wasn't designed to answer the question.
So now we're back in wait mode, as we have been for 15 years.
I wouldn't worry too much about weak hands. The bigger problem is the broken heads, backs, necks and legs!
Not to mention the blood and gore flying in all directions!
"Overall, the nCPAP failure rates through 72 hours after the start of treatment or randomization to the control group were 63% (15 min), 75% (30 min), 38% (45 min), 29% (60 min) and 38% (90 min) for the five AEROSURF groups compared to 53% in the control group. AEROSURF treatment of 45 minutes and greater (primarily single doses) appears to be associated with lower rates of nCPAP failure representing a 28% (45 and 90 min) and 45% (60 min) relative reduction in nCPAP failure compared to control."
nCPAP failure rates
Can anyone explain jump in the 90 minute reading. Does this mean maximum effectiveness is reached at 45 minutes to 60 minutes and that the device sould be disconnected after one hour to be reconnected again after some interval?
No longer content to do a single acquisition, we're now doing 3 acquisitions at a time.
My head is spinning. How will we count all our profits.
We'll have to walk away from the table!
True but it's priced as a 'stinker'.
We're in the unusual situation where, at the current pps, the cash available is ample to support a 10% dividend yield in the short to medium term. Mt. Market is in a dilemma:- does it knock another buck or two off the pps and send the dividend yield to an absurd 15% to 20% in an era where 1% interest on money is hard to get or does it bump the pps to bring the dividend yield to some semblance of sense?
Could we not just retain his services as CFO or, possibly Chairman & CFO?
How many biotechs do you know with rock-solid balance sheets despite never generating a profit?
90% effective! Wow, that blows Merck's Zostavax, with 51.3% efficacy, out of the water. Why would anyone even consider any other shingle's vaccine once this GSK's product hits the market.
In the current dysfunctional market, we could easily end the day the day in the red and that's after a p3 trial success in a multi-billion dollar market with no competition.
Something is very screwed up with US security markets.
I personally hope the reform being currently promised comes to fruition.
After 30 years investing in these markets, I'm now pulling out completely. Fundamentals never come into play in the way markets value many securities and that means we're in a table-skewed casino, not a stock market. Wall Street has taken us to the point of failure.